Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
44,565,097
-
Total 13F shares
-
3,895,041
-
Share change
-
+291,096
-
Total reported value
-
$160,245,480
-
Price per share
-
$41.14
-
Number of holders
-
28
-
Value change
-
+$11,976,287
-
Number of buys
-
22
-
Number of sells
-
3
Institutional Holders of Sionna Therapeutics, Inc. - Common Stock, $0.001 par value per share (SION) as of Q4 2025
As of 31 Dec 2025,
Sionna Therapeutics, Inc. - Common Stock, $0.001 par value per share (SION) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,895,041 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, Aberdeen Group plc, GEODE CAPITAL MANAGEMENT, LLC, TD Asset Management Inc, UBS Group AG, SEVEN GRAND MANAGERS, LLC, GOLDMAN SACHS GROUP INC, and Bank of New York Mellon Corp.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.